Heart Failure

Heart Failure - 2017 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/244042

Contents of this Issue

Navigation

Page 46 of 61

47 Important Comorbidities in HF Atrial Fibrillation Table 27. Clinical Evaluation in Patients With AF Minimum Evaluation 1. History and physical examination To define: Presence and nature of symptoms associated with AF Clinical type of AF (paroxysmal, persistent, or permanent) Onset of first symptomatic attack or date of discovery of AF Frequency, duration, precipitating factors, and modes of termination of AF Response to any pharmacological agents that have been administered Presence of any underlying heart disease or other reversible conditions (eg, hyperthyroidism or alcohol consumption) 2. ECG To define: Rhythm (verify AF) LV hypertrophy P-wave duration and morpholog y or fibrillatory waves Preexcitation Bundle-branch block Prior MI Other atrial arrhythmias To measure and follow the R-R, QRS, and QT intervals in conjunction with antiarrhythmic drug therapy 3. Transthoracic echocardiogram To identify: Valvular heart disease LA and RA size LV and RV size and function Peak RV pressure (pulmonary hypertension) LV hypertrophy LA thrombus (low sensitivity) Pericardial disease 4. Blood tests of thyroid, renal, and hepatic function For a first episode of AF, when the ventricular rate is difficult to control Reproduced from Fuster V, et al. Circulation. 2011;123:e269-e367.

Articles in this issue

view archives of Heart Failure - Heart Failure - 2017 Update